ClinicalTrials.gg
RecruitingNCT07613021IMT in weaningUpdated May 29, 2026

Effectiveness of Inspiratory Muscle Training in Weaning ICU Patients

An interventional study of IMT and Early mobilization in Mechanically Ventilated ICU Patients, sponsored by University of West Attica. Recruiting at 2 sites in Greece. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-05-29.

Sponsored by University of West Attica · Not applicable, Interventional, and Supportive care

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
45
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Patients in critical condition, due to their prolonged stay in the Intensive Care Unit (ICU), the severity of the underlying disease, and potential adverse effects of hospitalization, may develop serious complications, such as muscle atrophy and weakness, which also affect the respiratory muscles. It is characteristic that within the first 18-69 hours of mechanical ventilation (MV), proteolytic processes occur that lead to rapid atrophy of the diaphragm. Diaphragmatic dysfunction acquired during the ICU stay thus appears to have an adverse effect on weaning from mechanical ventilation, length of ICU stay, length of hospital stay, functional status, quality of life, and mortality within the ICU and the hospital. Inspiratory muscle training (IMT) has been identified as an intervention that could augment weaning, preventing the dedtrimental effects of MV. The purpose of this study is to assess the effect of an IMT protocol in weaning success of ICU patients. Specifically, an electronic device will be used that incorporates a tapered flow resistive technique.

Read the detailed description

It is estimated that 40% of the duration of mechanical ventilation is devoted to the weaning process. A length of stay in the ICU of more than 7 days appears to be associated with a 27,9% risk of developing infections. Furthermore, the mortality rate is higher in patients with infections. Additionally, the daily cost of hospitalizing a patient on mechanical ventilation is estimated at €1,590-€1,657, while this varies depending on the interventions required. The burden on the National Health System from the prolonged stay of patients in the ICU, as well as from the complications that will arise, increases exponentially.

It has been found that implementing an IMT program can lead to rapid and successful extubation of the patient, while early mobilization can accelerate timely discharge from the ICU. This optimizes the cost-effectiveness ratio in intensive care units.

The investigators believe that implementing an IMT program will maximize the effectiveness of the early mobilization program for ICU patients. Thus, the investigators believe it will provide valuable insights into the rehabilitation needs of critically ill patients, contributing to earlier weaning from mechanical ventilation and transition to the next level of care. The investigators hypothesize that the implementation of such an intervention program will reduce the length of hospital stay, while also lowering the cost of daily care.

This is a randomized control trial that investigates the effectiveness of an inspiratory muscle training program in successful weaning of mechanically ventilated patients for at least 72 hours. Both experimental groups will receive a protocolised early mobilization program. IMT intervention will be applied till ICU discharge once a day for 5 days/week initiating with a load of 40% of maximal inspiratory pressure (MIP). Primary outcome will be a successful weaning from MV. And secondary includes MV duration, MIP, maximal expiratory pressure (MEP), ICU and hopsital length of stay.

02

Conditions studied

  • Mechanically Ventilated ICU Patients

Keywords

  • Inspiratory Muscle training
  • Weaning
  • Maximal Inspiratory pressure
  • Intensive Care Unit
03

In context

Lead sponsor

University of West Attica is the lead sponsor of 31 studies on the registry; 13 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • ≥ 72h invasive mechanical ventilation
  • adequate co-operativeness as assessed by 5SQ ≥ 3.

Exclusion criteria

Exclusion Criteria:

  • terminal condition or palliative care
  • neuromuscular or neurological conditions prior to ICU admission
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
45 participants (estimated)

Study arms

  • Experimental
    IMT Group

    Inspiratory muscle training will be performed using an electronic breathing trainer (40% of MIP, with a daily increase of 10% of the initial MIP) and 30 repetitions, organized into 3 sets of 10 repetitions with a 1-minute break between sets. Additional, a protocolized early mobilization program will be perfromed.

    Other: IMT · Other: Early mobilization

  • Active comparator
    Control Group

    A protocolized early mobilization program

    Other: Early mobilization

Interventions

  • OtherIMT

    Inspiratory muscle training will be performed using an electronic breathing trainer (40% of MIP, with a daily increase of 10% of the initial MIP) and 30 repetitions, organized into 3 sets of 10 repetitions with a 1-minute break between sets

  • OtherEarly mobilization

    Protocolized early mobilization program

06

What researchers measure

Primary outcomes

  1. Weaning sucess

    Successful weaning is defined as the removal of the endotracheal tube with no ventilator support for 48 hours following its removal

    Time frame: immediately after intervention

Secondary outcomes

  1. Weaning duration

    Duration of weaning procedure

    Time frame: immediately after intervention

  2. Maximal Inspiratory Pressure

    Maximal inspiratory Pressure

    Time frame: 1st day (baseline), immediately after intervention

  3. Maximal expirartory pressure

    Time frame: 1st day (baseline), immediately after intervention

07

Study locations

2 of 2 sites recruiting
  • General Hospital
    Chalcis, Greece
    Recruiting
  • General Hospital "Agios Panteleimon"
    Nikaia, Greece
    Recruiting
    • Stavroula Fokidi, MSc · Contactsfokidi@uniwa.gr · +306942064363
    • Stavroula Fokidi, MSc · Principal investigator
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Apr 2026; primary completion for Jun 2029, 38 months later.

How these figures are worked out, and which studies are left out of them.

Registered
May 5, 2026
First posted
May 29, 2026
StartEst.
Apr 2026
Primary completionEst.
Jun 2029
CompletionEst.
Dec 2029
Last update
May 29, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 29, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07613021
Lead sponsor
University of West Attica
Collaborators
General Hospital of Chalkida, General Hospital of Nikaia "Saint Panteleimon"
Responsible party
IRINI PATSAKI (Assistant Professor, University of West Attica) — Principal investigator
First posted
May 29, 2026
Start date
Apr 2026 (estimated)
Primary completion
Jun 2029 (estimated)
Completion
Dec 2029 (estimated)
Last update
May 29, 2026

Study contacts

IRINI PATSAKI, PhD
Contact
ipatsaki@uniwa.gr
+30 6942064363

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion